WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 1.86.
| Share Price | ₹764.7 | Apr 01,2026 |
| Market Cap | ₹1,613.4 Cr | |
| Sales-TTM | ₹868.3 Cr | TTM-Consolidated Results |
| Price/Sales | 1.86x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,613.4 Cr] as on Apr 01,2026
(/) Sales [ ₹868.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.86x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '1.86 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.29x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 0.98x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2025 at 2.87x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WINDLAS BIOTECH | 868.3 | 1.86 | 1,613.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.30 | 414,713.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.20 | 156,811.0 |
| CIPLA LTD | 28,351.1 | 3.41 | 96,602.7 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 10.91 | 139,052.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.91 | 100,927.0 |
| MANKIND PHARMA LTD | 13,914.1 | 5.94 | 82,613.1 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.33 | 86,883.3 |
| LUPIN LTD | 26,150.5 | 3.97 | 103,944.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.35 | 77,949.4 |
| ABBOTT INDIA LTD | 6,824.1 | 8.25 | 56,293.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.86x |
| Max industry PS | 15.20x |
| Median industry PS | 3.97x |
| Average industry PS | 5.95x |
You may also like the below Video Courses